Clinical trials
Inflammatory Breast Neoplasms trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| Brigham and Women's Hospital | 1 |
| Clayton State University | 1 |
| Dana-Farber Cancer Institute | 1 |
| National Cancer Institute (NCI) | 1 |
| Scott and White Hospital & Clinic | 1 |
| The University of Tennessee, Knoxville | 1 |
| Wake Forest University Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammatory Breast Neoplasms | 9 |
| Breast Neoplasms | 8 |
| Breast Carcinoma In Situ | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Agnosia | 1 |
| Cancer Pain | 1 |
| Fatigue | 1 |
| Hot Flashes | 1 |
| Melanoma | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.